Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

reGeneRative bone Implant for the treatment of hip dysPlasia

Project description

Personalised regenerative implants for hip dysplasia

Hip dysplasia is a condition associated with the misalignment of the bones of the hip joint. It usually occurs when the socket in the pelvis is too shallow to fit the femoral head. Corrective surgery is the usual treatment option, but it has limited success. The ERC-funded GRIP project has developed a novel implant with bone-inducing properties for correcting hip dysplasia. The implant is personalised to meet the anatomical requirements of each individual patient, ensuring a perfect fit. Importantly, its regenerative capacity guarantees stable and long-term integration into the patient’s native bone.

Objective

GRIP develops a personalised, 3D-printed regenerative bone implant as a treatment for hip instability (hip dysplasia) and its commercialisation strategy. Osteoarthritis (OA) of the hip is a painful and debilitating condition and hip dysplasia is one of the two main causes. The currently most common surgical methods to correct the dysplasia involve the re-alignment of the hip socket (osteotomy) or the insertion of a bone graft to enlarge the socket (shelf arthroplasty). While the osteotomy is invasive, the shelf arthroplasty requires donor tissue. In addition, both procedures only have limited success rates. GRIP implants overcome the current shortcomings of these methods and provide a novel personalized implant to treat hip dysplasia. GRIP will provide patients and surgeons with an easy to use, one-step and cost-effective regenerative device, therefore overcoming the significant drawbacks with current treatments for hip dysplasia. The GRIP implants will be precisely fabricated from a flexible bone-inducing biomaterial through a process both developed and established within the ERC-CoG “3D-JOINT” project. This will ensure a perfect fit, resulting in optimal integration and durable restoration of the hip socket, as well as obviating the need for complex and invasive osteotomy surgeries. GRIP implants will revolutionise the treatment of hip dysplasia as they provide a stable, long-term, and regenerative solution that will fully integrate with the host bone tissue. Moreover, the regenerative nature will also make this a potential treatment option for younger (paediatric) patients. As GRIP will transform the treatment of hip dysplasia and will improve long-term health and well-being of both human and veterinary patients the economic value and the route to the market for the GRIP technologies will be explored.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-POC1

See all projects funded under this call

Host institution

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Net EU contribution
€ 150 000,00
Address
HEIDELBERGLAAN 100
3584 CX Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)